Huang et al. found that PI3K/Akt pathway is inactivated after podocyte injury, and Notoginsenoside R1 (NR1) treatment reactivates this pathway and further improves DKD (Huang et al. 2017). This evidence concerns the gene AKT1 and diabetic kidney disease.